Thyroid hormone decreases the expression of epidermal growth factor receptor

The receptors for epidermal growth factor (EGF) and thyroid hormone (T3) are prototypes, respectively, of transmembrane signaling proteins and nuclear transcription regulatory proteins. Oncogenic homologs of these two receptor genes, v-erbB and v-erbA, cooperate with each other in cellular transform...

Full description

Saved in:

Bibliographic Details
Published in:	The Journal of biological chemistry Vol. 266; no. 16; pp. 10282 - 10286
Main Authors:	KESAVAN, P, MUKHOPADHYAYA, S, MURPHY, S, RENGUARAJU, M, LAZAR, M. A, DAS, M
Format:	Journal Article
Language:	English
Published:	Bethesda, MD American Society for Biochemistry and Molecular Biology 05-06-1991
Subjects:	Biological and medical sciences Blotting, Northern Blotting, Western Cell Line Cell physiology DNA Probes Down-Regulation ErbB Receptors - metabolism Fundamental and applied biological sciences. Psychology Genes, Regulator Humans Molecular and cellular biology Precipitin Tests Receptors, Thyroid Hormone - metabolism Responses to growth factors, tumor promotors, other factors RNA, Messenger - analysis Thyroid Hormones - metabolism Transcription, Genetic Human Cell culture Aminoacid derivative hormone Gene expression Northern blotting Immunoprecipitation reaction Membrane receptor Epidermal growth factor Cell line Messenger RNA Thyroxine Immunoblotting assay Growth factor
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	The receptors for epidermal growth factor (EGF) and thyroid hormone (T3) are prototypes, respectively, of transmembrane signaling proteins and nuclear transcription regulatory proteins. Oncogenic homologs of these two receptor genes, v-erbB and v-erbA, cooperate with each other in cellular transformation and blockage of erythrocytic differentiation. As a first step toward investigating this cooperation, we have studied the relationship between the normal homologs of these two receptors in A431 cells. Treatment of these cells with T3 has no significant effect on EGF receptor gene transcription but leads to a drastic decrease in the steady-state level of receptor mRNA. The down-regulatory effect is visible by 2 h and persists up to 8 h, but EGF receptor mRNA returns to normal (sometimes higher than normal) level by 48-72 h. The T3-induced decrease in EGF receptor mRNA (found during 2-8 h of T3 treatment) is due to a specific destabilization of EGF receptor mRNA. The 5.6-kb mRNA that encodes the full-length transmembrane EGF receptor is preferentially degraded. The half-life of the 2.6-kb mRNA that encodes the aberrant C-terminally truncated receptor is unaffected by T3. In other studies we found that T3 decreases the rate of synthesis of the full-length EGF receptor protein and reduces its steady-state amount. Overall the results demonstrate a negative regulatory effect of T3 in post-transcriptional control of EGF receptor expression, and raise interesting questions regarding the mechanism of this down-regulation, and the possible roles of T3 receptors in the control of EGF receptor function.
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2
ISSN:	0021-9258 1083-351X
DOI:	10.1016/S0021-9258(18)99222-7